GLTO
GLTO
NASDAQ · Biotechnology

Galecto Inc

$25.50
-0.13 (-0.51%)
As of Mar 29, 10:51 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -34.1% upside
Low Target $13.00
Average Target $16.81
High Target $24.93
Current Price $25.50
Current
$25.50
Target
$16.81
$13.00 $16.81 avg $24.93
Scenario Analysis
Bear Case
$13.00
-49.0%
Low target
Base Case
$16.81
-34.1%
Avg target
Bull Case
$24.93
+-2.2%
High target
Risk/Reward
0.0x
Unfavorable
Price in Context
52-Week High
$38.33
-33.5% from high
52-Week Low
$2.01
+1,168.7% from low
Target vs 52W High
$16.81
-56.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%